transformed cell types. Efficiency of insertion ranged from 7% to 57% and was cell-type-dependent (Supplementary Fig. 2) . Sequencing of modified A549 cell clones (using ssODN AAVS1-115, Supplementary Note 1) confirmed that the insertion was correctly targeted and stable (Supplementary Fig. 3 ). To determine the minimal homology requirements in the ssODN, we systematically reduced the length of total homology of AAVS1 ssODNs over the 100 base to 30 base range (Supplementary Note 1). We observed a drop in efficiency on transition from 40 to 30 total bases of homology ( Supplementary Fig. 4 ). We did not detect HindIII site insertion using ssODNs distal to the cut site (for example, 0.1-1 kb away; data not shown). The extent of modification achieved using an ssODN donor was approximately twofold higher than that obtained using a plasmid donor ( Supplementary  Fig. 5 ). The single-stranded format of oligodeoxynucleotides resulted in fewer (if any) nonfaithful integrations at the doublestrand break than a double-stranded oligodeoxynucleotide composed of the same ssODN and its complement ( Supplementary  Fig. 6 ). Expressing ZFNs in either plasmid DNA or mRNA format enabled efficient ssODN-mediated targeting, with mRNA giving ~1.4-fold higher frequency of targeting under these experimental conditions (Supplementary Fig. 7) . With the exception of data shown in Supplementary Figures 4 and 7 , all data reported in this paper were collected using capped poly(A)-tailed mRNA for ZFN expression.
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The preceding studies at the AAVS1 locus demonstrated ssODN-mediated modification directly at the cut site. In practice, however, it is rarely possible to generate ZFNs that cut precisely at the desired point of mutation. We attempted to create a targeted codon modification in the RPS6KA3 gene encoding the kinase RSK2, implicated in mental retardation, psychomotor and skeletal disorders, and in cancer. Previous data with exogenous RSK2 predicted that a cysteine to valine conversion in the active site will render RSK2 insensitive to the pharmacological RSK kinase inhibitor fmk 11, 12 . We sought to recreate this 3-bp mutation at the endogenous RPS6KA3 locus (here we refer to it by the synonym RSK2) using the ssODN-based approach. We engineered a ZFN that cuts 27 bp away from the desired mutation site in RSK2. We designed an ssODN donor (ssODN RSK2-125) to span both the mutation site and the ZFN cleavage site as well as flanking sequence (Fig. 1a and Supplementary Note 1) . To enable restriction fragment length polymorphism (RFLP)-based detection of targeted clones, we introduced a silent cytosine to adenine mutation to create a BamHI restriction site 15 bp from the Cys436 codon location, but on the opposite side of Cys436 codon to the ZFN binding site and 42 bp away from the cleavage site. Thus, if the integration of the ssODN occurs via the directional high-frequency genome editing using ssdna oligonucleotides with zinc-finger nucleases Zinc-finger nucleases (Zfns) have enabled highly efficient gene targeting in multiple cell types and organisms. here we describe methods for using simple ssdna oligonucleotides in tandem with Zfns to efficiently produce human cell lines with three distinct genetic outcomes: (i) targeted point mutation, (ii) targeted genomic deletion of up to 100 kb and (iii) targeted insertion of small genetic elements concomitant with large genomic deletions.
Predefined genomic modifications using zinc-finger nucleases (ZFNs) are typically achieved using donor plasmids that contain homology arms of 200-800 base pairs (bp) flanking the genomic site of modification 1,2 . These donor plasmids are smaller and simpler to build than traditional gene-targeting vectors, yet they still require several weeks to construct. In contrast, singlestranded oligodeoxynucleotides (ssODNs) can be designed and synthesized in just a few days. Substituting plasmid donors with ssODNs would greatly expedite ZFN-based gene targeting studies. Homologous recombination-mediated targeted genome editing in eukaryotic cells is greatly stimulated by targeted double-strand breaks [1] [2] [3] [4] [5] . Recent genome-editing work using ssODNs with I-SceI endonuclease and ZFNs has achieved correction of reporter genes at frequencies of up to 0.7% (refs. 6,7). Here we report routine, efficient and experimentally flexible targeted genome editing using ZFNs and ssODNs at endogenous loci. Double-strand break-facilitated gene conversion is most efficient near the break site 8 , so we chose first to insert a restriction site directly into a ZFN cleavage site in the AAVS1 locus 9,10 using the ssODN AAVS1-95 (numbers indicate total oligo length; here 95 nucleotides), which contained a HindIII site flanked by ~40 bp of homology on each side of the ZFN cut site ( Supplementary  Fig. 1 and Supplementary Note 1). We readily detected targeted insertion of the HindIII site in pooled cells in seven different homologous recombination mechanisms previously characterized for dsDNA donors 8 , the majority of BamHI site-containing alleles would be expected to contain the mutation encoding C436V. Finally, we included two silent ZFN-blocking mutations in the ZFN binding site. When incorporated into the target locus, the ZFN-blocking mutations disrupt the ZFN target site, thereby protecting the modified locus from additional cutting by the ZFNs after gene conversion, which could otherwise result in unwanted small deletions or insertions via nonhomologous end-joining repair. Although not absolutely required, ZFN-blocking mutations are advantageous in analogous plasmid-based codon conversion experiments (data not shown). Upon transfection of ssODN RSK2-125 and mRNA encoding the RSK2 ZFN into K562 cells, we detected the BamHI site conversion at rates of 22-32% as estimated by RFLP assay (Fig. 1b) . Single-cell cloning yielded at least 20 clones from ~750 (3%) with biallelic BamHI conversion and the desired biallelic C436V conversion (Supplementary Fig. 8 ). Thus, creation of mutations at substantial distances (42 bp in this instance) from the ZFN cut site using ssODNs is feasible and efficient. Sequence-based analysis of the fidelity of these modifications showed this approach enables isolation of correctly targeted mutant clones (Supplementary Fig. 9 ). Three randomly selected clones encoding the C436V mutant demonstrated the predicted insensitivity of RSK2 to fmk (Fig. 1c) .
Targeted deletion of exons or entire genes is also a frequently desired outcome in genome editing. To date, most ZFN-mediated genomic deletions have resulted from capturing misrepair events during nonhomologous end joining 13 of targeted double-strand breaks. Deletions arising from the use of a single ZFN pair are typically <50 bp. Larger deletions can be obtained by using two ZFN pairs that cleave at a prescribed distance from each other on the same chromosome and excise the intervening sequence 14, 15 , but this approach may be offset by the need to generate additional ZFNs that target at each boundary of the deletion. A simple and efficient process whereby a single ZFN can be used to generate large deletions in a defined manner is needed. Similar to previous work in yeast 16 , we investigated the use of ssODNs to facilitate deletion between a mammalian double-strand break and a distal locus in the same chromosome that is uniquely specified by the design of the ssODN. In Figure 2a we illustrate the general design used for deletion ssODNs (nucleotide resolution designs for various loci are shown in Fig. 2b and Supplementary Notes 2 and 3). We synthesized ssODNs to operate in concert with the ZFNs targeting the AAVS1 locus. We chose distal deletion points to systematically investigate the effect of deletion size without regard to genetic or sequence specific genomic context. We generated chromosomal deletions 0.1-100 kilobases (kb) in size extending from the ZFN cut site ( Fig. 2c and Supplementary Note 2). First we screened clones from transfected K562 cells by PCR with primers flanking the respective deletion boundaries to identify those in which the deletion had occurred. Then, to detect remaining alleles where deletion had not occurred, we screened clones containing the deletion by junction PCR using one primer that bound inside the deleted region and another that bound outside the deleted region. In K562 cells the AAVS1 locus is triploid. Nevertheless, the PCR data from the clones indicate that we isolated complete triallelic deletions of 1 kb, 5 kb and 10 kb at frequencies of 2.9%, 0.6% and 0.2%, respectively, after a single ZFN treatment (Supplementary Table 1 and Supplementary Figs. 10-12) . We verified PCR data indicating a triallelic 10 kb deletion by Southern blotting ( Supplementary  Figs. 13 and 14) . In K562 cells, smaller deletions at the AAVS1 locus of 100 bp and 500 bp produced higher triallelic deletion rates of 21% and 10.8%, respectively, as assessed by analysis of singlecell clones (Supplementary Table 1 and Supplementary Fig. 15 ). PCR screening >1,000 clones identified two isolates heterozygous for 100-kb deletions ( Supplementary Fig. 16 and Supplementary Table 1 ). We tested this deletion method in seven different cell lines and on four different genes (Supplementary Fig. 17 ). Also we attempted simultaneous deletion in both the 5′ and 3′ directions from the AAVS1 ZFN cut site by transfecting K562 cells with AAVS1 ZFNs and two ssODNs designed to achieve 100-bp deletions in each direction. PCR sequencing of the target locus identified deletion events that were exclusively in one direction or the other but never in both directions (data not shown). Also we generated large C436V mutant in K562 cells with wild-type or ssODN-mutated RSK2 C436V (three clones) treated with fmk and phorbol 12-myristate 13-acetate (PMA) to stimulate ERK that activates RSK2 as indicated. Cell extracts were immunoprecipitated with antibodies to RSK2 and the precipitates immunoblotted with antibodies to active phosphorylated hydrophobic motif of RSK2 (anti-pHM RSK2) that detect active RSK2 or to total RSK2 (anti-RSK2). Pre-precipitation cell extracts were immunoblotted with antibodies to phosphoERK (anti-pERK) that detect active ERK or to total ERK (anti-ERK).
deletions concomitant with insertion of short sequences such as a loxP recombinase site (Supplementary Fig. 18 ).
Earlier studies using ssODNs for targeted gene modification had documented adverse cellular responses, raising concerns as to the viability and safety of ssODN-mediated approaches 6, 17, 18 . A common aspect of these studies was the use of ssODNs containing phosphorothioate linkages. A recent study has demonstrated that the observed toxicity is due to the presence of the phosphorothioate modification, and that ssODNs themselves have little impact on cell integrity 18 , consistent with other work in mammalian cells 7 and in yeast 16 . We conducted our experiments with unmodified ssODNs and did not observe adverse cellular responses. Moreover, we isolated clones even from pools that had undergone relatively low frequency modifications. We advise that ssODNs be free of phosphorothioate modification and that the impact of any other type of modification be assessed. We encourage others to be aware that although ZFN-induced double-strand breaks greatly increase genome-editing frequencies, cell types can vary greatly in their response to various nucleic acid delivery methods and DNA repair responses. For a given cell type, initial RFLP-based assessment (Fig. 1b and Supplementary Figs. 1 and 2) can be used to rapidly determine whether delivery efficiencies, ZFN expression and DNA repair rates are sufficiently high to merit expansion and screening of clones in the absence of selection.
In conclusion, we found that ssODNs can be used with precisely localized ZFNs to achieve three distinct genetic modification events: (i) targeted point mutation, (ii) targeted deletion of small and large sequences and (iii) simultaneous targeted deletion of large sequences and insertion of defined small genetic elements. These events can be achieved at frequencies of 1-30% without antibiotic selection, and we tested the approach for multiple loci and transformed cell types. ssODNs and ZFNs have also recently been reported to be effective at genome editing in human induced pluripotent stem cells 19 . The trivial task of synthesizing ssODN donors provides the researcher with greater freedom and speed to conduct sophisticated genetic modification in mammalian cells and likely in other eukaryotic systems. The expected fragment sizes of the wildtype and deletion alleles are indicated. PCR fragments greater than 1.5 kb were not detected under the experimental conditions. M, DNA marker (Sigma); *3′ deletion from the ZFN cut site; **5′ and 3′ deletion off the ZFN cut site by transfecting both d5-AAVS1-0.1kb and d3-AAVS1-0.1kb deletion ssODNs; supplementary note 2); all other lanes are 5′ deletions from the cut site. 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 Deletion PCR assay. Genomic DNA was extracted from transfected cells with GenElute Mammalian Genomic DNA Miniprep kit 2 d after nucleofection. Genomic DNA was then PCRamplified for each targeted deletion event with a pair of primers positioned outside of the corresponding deleted sequence (see Supplementary Table 2 for all PCR primer sequences). For deletions 5′ to the ZFN cut site at the AAVS1 locus, a common reverse primer, AAVS1-d5R-com, was paired with each of the following 5′ deletion-specific forward primers: AAVS1-dF-0.1 (100-bp deletion), AAVS1-d5F-0.5 (500-bp deletion), AAVS1-d5F-1 (1-kb deletion), AAVS1-d5F-1.5 (1.5-kb deletion), AAVS1-d5F-2 (2-kb deletion), AAVS1-d5F-2.5 (2.5-kb deletion), AAVS1-d5F-3 (3-kb deletion), AAVS1-d5F-3.5 (3.5-kb deletion), AAVS1-d5F-4 (4-kb deletion), AAVS1-d5F-4.5 (4.5-kb deletion), AAVS1-d5F-5 (5-kb deletion), AAVS1-d5F-10 (10-kb and 10.1-kb deletions), AAVS1-d5F-20 (19.9-kb and 20-kb deletions), AAVS1-d5F-50 (50-kb deletion) and AAVS1-d5F-100 (100-kb deletion). For the concerted 5′ 5-kb deletion and loxP insertion at the AAVS1 locus, primers AAVS1-dR-com and AAVS1-dF-5 were used. For the junction-specific PCR, AAVS1-dR-com was used with the forward junction-specific primer, AAVS1-dloxP. For deletions 3′ to the ZFN cut site at the AAVS1 locus, a common forward primer, AAVS1-d3F-com, was paired with each of the two 3′ deletionspecific reverse primers: AAVS1-d3R-0.1 (100-bp deletion) and AAVS1-d3R-2 (2-kb deletion).
The primer pairs used to analyze the deletion events at other loci were IRAK4-d5F-5.9 and IRAK4-d5R-5.9 (5′ 5.9-kb deletion), RSK2-d3F-5.2 and RSK2-d3R-5.2 (3′ 5.2-kb deletion), and RSK4-d3F-5 and RSK4-d3R-5 (3′ 5-kb deletion). The amplification was carried out with JumpStart Taq ReadyMix using the following cycling condition: 98 °C for 2 min for initial denaturation; 35 cycles of 98 °C for 15 s, 62 °C for 30 s and 72 °C for 30 s; and a final extension at 72 °C for 5 min. PCR products were resolved on 3% agarose gel. Deletion PCR fragments were verified by DNA sequencing.
